Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial
Anne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber, Karsten Gjessing Jensen, Ditte Ruda, Marie Stentebjerg-Olesen, Peter Jantzen, Simone Rasmussen, Eva Ann-Sofie Saldeen, Maj-Britt Glenn Lauritsen, Niels Bilenberg, Anne Dorte Stenstrom, Louise Nyvang, Sarah Madsen, Thomas M. Werge, Theis Lange, Christian Gluud, Maria Skoog, Per Winkel, Jens Richardt M. JepsenBirgitte Fagerlund, Christoph U Correll, Anders Fink-Jensen
Dive into the research topics of 'Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial'. Together they form a unique fingerprint.